发明名称 |
Alteration of sequence of a target molecule |
摘要 |
Method for splicing a target nucleic acid molecule with a separate nucleic acid molecule. Such splicing generally causes production of a chimeric protein with advantageous features over that protein naturally produced from the target nucleic acid prior to splicing. The method includes contacting the target nucleic acid molecule with a catalytic nucleic acid molecule including the separate nucleic acid molecule. Such contacting is performed under conditions in which at least a portion of the separate nucleic acid molecule is spliced with at least a portion of the target nucleic acid molecule to form a chimeric nucleic acid molecule. In this method, the catalytic nucleic molecule is chosen so that it is not naturally associated with the separate nucleic acid molecule. |
申请公布号 |
AU1175795(A) |
申请公布日期 |
1995.05.29 |
申请号 |
AU19950011757 |
申请日期 |
1994.11.09 |
申请人 |
RIBOZYME PHARMACEUTICALS, INC. |
发明人 |
BRUCE A SULLENGER;THOMAS R. CECH |
分类号 |
C12N15/00;A61K38/00;A61K48/00;C07H21/04;C12N9/00;C12N15/113 |
主分类号 |
C12N15/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|